0001925270-22-000002.txt : 20220429 0001925270-22-000002.hdr.sgml : 20220429 20220429095942 ACCESSION NUMBER: 0001925270-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 EFFECTIVENESS DATE: 20220429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kelonia Therapeutics, Inc. CENTRAL INDEX KEY: 0001925270 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-443816 FILM NUMBER: 22871130 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 503-703-1299 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001925270 Kelonia Therapeutics, Inc. 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 503-703-1299 DELAWARE Elcano Therapeutics, Inc. Viralogic Therapeutics, Inc. None Corporation true 2020 Kevin Friedman c/o Kelonia Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Michael Birnbaum c/o Kelonia Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Michael Fischbach c/o Kelonia Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Bryan Roberts c/o Kelonia Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Bob More c/o Kelonia Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2022-04-14 false true false 0 50299983 50299983 0 false 8 0 0 0 false Kelonia Therapeutics, Inc. /s/ Kevin Friedman Kevin Friedman President 2022-04-29